These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2958141)

  • 21. Acceptance of class II major histocompatibility complex disparate skin grafts associated with suppressor cells and elevated Langerhans cell numbers.
    Odling KA; Halliday GM; Muller HK
    Pathology; 1992 Jul; 24(3):184-9. PubMed ID: 1437291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice.
    Desvignes C; Bour H; Nicolas JF; Kaiserlian D
    Eur J Immunol; 1996 Aug; 26(8):1756-61. PubMed ID: 8765017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for prostaglandins in the suppression of cutaneous cellular immunity and tumour development in benzo(a)pyrene- but not dimethylbenz(a)anthracene-treated mice.
    Andrews J; Halliday GM; Muller HK
    Clin Exp Immunol; 1991 Jul; 85(1):9-13. PubMed ID: 1906386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinogen-induced depletion of cutaneous Langerhans cells.
    Muller HK; Halliday GM; Knight BA
    Br J Cancer; 1985 Jul; 52(1):81-5. PubMed ID: 3925975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble factors in tolerance and contact sensitivity to DNFB in mice. VI. Cellular and lymphokine requirements for stimulating suppressor factor production in vitro.
    Fairchild RL; Moorhead JW
    J Immunol; 1986 Oct; 137(7):2125-31. PubMed ID: 2944949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigating the roles of regulatory T cells, mast cells and interleukin-9 in the control of skin inflammation by vitamin D.
    Gorman S; Geldenhuys S; Weeden CE; Grimbaldeston MA; Hart PH
    Arch Dermatol Res; 2018 Apr; 310(3):221-230. PubMed ID: 29392411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of suppressor T cells and inhibition of contact hypersensitivity in mice by 12-O-tetradecanoylphorbol-13-acetate and its analogs.
    Kodari E; Pavone A; Reiners JJ
    J Invest Dermatol; 1991 Jun; 96(6):864-70. PubMed ID: 1828476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinogen-induced inflammation and immunosuppression are enhanced in xeroderma pigmentosum group A model mice associated with hyperproduction of prostaglandin E2.
    Miyauchi-Hashimoto H; Kuwamoto K; Urade Y; Tanaka K; Horio T
    J Immunol; 2001 May; 166(9):5782-91. PubMed ID: 11313422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strain variation in the induction of tolerance by epicutaneous application of trinitrochlorobenzene.
    Sauder DN; Katz SI
    J Invest Dermatol; 1983 May; 80(5):383-6. PubMed ID: 6221052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Langerhans cells: sentinels of skin associated lymphoid tissue.
    Toews GB; Bergstresser PR; Streilein JW
    J Invest Dermatol; 1980 Jul; 75(1):78-82. PubMed ID: 7391612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization of contact allergy to DNFB in mice. I. Description of a model system.
    Claman HN; Jaffee BD
    J Immunol; 1983 Dec; 131(6):2682-6. PubMed ID: 6227661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressor T cell circuits in contact sensitivity. I. Two mechanistically distinct waves of suppressor T cells occur in mice tolerized with syngeneic DNP-modified lymphoid cells.
    Miller SD; Butler LD; Claman HN
    J Immunol; 1982 Aug; 129(2):461-8. PubMed ID: 6211486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific suppressor T cells in rats active in the afferent phase of contact hypersensitivity.
    Prop J; Griffiths A; Hutchinson IV; Morris PJ
    Cell Immunol; 1986 Apr; 99(1):73-84. PubMed ID: 2428531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitizing capacity of Langerhans' cells obtained from ultraviolet-B-exposed murine skin.
    Dai R; Streilein JW
    Immunology; 1995 Dec; 86(4):661-7. PubMed ID: 8567035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival.
    McMinn PC; Halliday GM; Muller HK
    Immunology; 1990 Sep; 71(1):46-51. PubMed ID: 1698716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble factors in tolerance and contact sensitivity to DNFB in mice. X. IL-2 is the activation signal mediating release of synthesized suppressor factor.
    Fairchild RL; Moorhead JW
    Cell Immunol; 1991 Mar; 133(1):147-60. PubMed ID: 1825030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells.
    Maeda A; Beissert S; Schwarz T; Schwarz A
    J Immunol; 2008 Mar; 180(5):3065-71. PubMed ID: 18292529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Migration of Langerhans cells from carcinogen-treated sheep skin.
    Dandie GW; Ragg SJ; Muller HK
    J Invest Dermatol; 1992 Nov; 99(5):51S-53S. PubMed ID: 1431210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression.
    Woods GM; Doherty KV; Malley RC; Rist MJ; Muller HK
    Immunology; 2000 Jan; 99(1):16-22. PubMed ID: 10651936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.